Shimada M

No ORCID on file · 9 papers in corpus · active 2003-2026

Study types

  • case-report 2

Condition tags

  • endometriosis 2
  • endometrioma 1
  • bladder_endometriosis 1
2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study.
Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-026-04324-z

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

2024
Comprehensive serum glycopeptide spectra analysis to identify early-stage epithelial ovarian cancer.
Scientific reports ·doi:10.1038/s41598-024-70228-6

Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new method, named Comprehe…

2023
Diagnostic Performance of Preoperative Imaging in Endometrial Cancer.
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30090597

BackgroundEndometrial cancer is one of the most common gynecological malignancies. Because the findings mentioned in radiogram interpretation reports issued by diagnostic radiologists influence treatment strategies, we aimed to evaluate the…

2023
Impact of FKBP52 on cell proliferation and hormone-dependent cancers.
Cancer science ·doi:10.1111/cas.15811

FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain-containing peptidylprolyl isom…

2021
Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125.
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100847

ObjectiveOvarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The con…

2019
Self-expandable metallic stenting as a bridge to surgery for malignant colorectal obstruction: pooled analysis of 426 patients from two prospective multicenter series.
Surgical endoscopy ·doi:10.1007/s00464-018-6324-8

BackgroundSelf-expandable metallic stenting (SEMS) for malignant colorectal obstruction (MCO) as a bridge to elective surgery (BTS) is a widely used procedure. The aim of this study was to assess short-term outcomes of SEMS for MCO as BTS.M…

2017
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
Journal of gynecologic oncology ·doi:10.3802/jgo.2017.28.e54

There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and tr…

case-report 2012
[A case of vesical endometriosis that worsened during the early pregnancy period]
Hinyokika kiyo. Acta urologica Japonica

We report a case of vesical endometriosis that worsened during the early pregnancy period. A 37-year old woman had been under treatment for endometriosis (including vesical endometriosis) by a gynecologist during the past 10 years. She was …

case-report 2003
Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman
Gynecologic oncology ·doi:10.1016/j.ygyno.2003.08.005

BACKGROUND: The risk of ovarian cancer increases in women with a long history of ovarian endometriosis, particularly in postmenopausal women. We present here a case of malignant transformation of endometriosis occurring over a short time in…